Key stats
About China Southern Hang Seng Biotechnology Exchange Traded Fund Units
Home page
Inception date
Jun 17, 2022
Structure
Open-Ended Fund
Replication method
Physical
Dividend treatment
Distributes
Primary advisor
China Southern Asset Management Co., Ltd.
ISIN
CNE100005G99
Closely track underlying index,Tightly track the target and minimize the deviation
Classification
Returns
| 1 month | 3 months | Year to date | 1 year | 3 years | 5 years | |
|---|---|---|---|---|---|---|
| Price performance | — | — | — | — | — | — |
| NAV total return | — | — | — | — | — | — |
What's in the fund
Exposure type
Health Technology
Stocks99.55%
Health Technology86.94%
Distribution Services4.75%
Consumer Non-Durables3.67%
Technology Services1.88%
Commercial Services1.35%
Health Services0.94%
Retail Trade0.01%
Bonds, Cash & Other0.45%
Cash0.45%
Stock breakdown by region
Asia90.72%
Europe9.28%
North America0.00%
Latin America0.00%
Africa0.00%
Middle East0.00%
Oceania0.00%
Top 10 holdings
Dividends
Dividend payout history
Assets under management (AUM)
Fund Flows
Frequently Asked Questions
159615 invests in stocks. The fund's major sectors are Health Technology, with 86.94% stocks, and Distribution Services, with 4.75% of the basket. The assets are mostly located in the Asia region.
159615 top holdings are Wuxi Biologics (Cayman) Inc. and BeOne Medicines Ltd., occupying 10.43% and 9.24% of the portfolio correspondingly.
159615 assets under management is 520.05 M CNY. It's risen 33.00% over the last month.
159615 fund flows account for −3.26 M CNY (1 year). Many traders use this metric to get insight into investors' sentiment and evaluate whether it's time to buy or sell the fund.
No, 159615 doesn't pay dividends to its holders.
159615 shares are issued by China Southern Asset Management Co., Ltd. under the brand China Southern. The ETF was launched on Jun 17, 2022, and its management style is Passive.
159615 expense ratio is 0.65% meaning you'd have to pay 0.65% of your investment to help manage the fund.
159615 follows the Hang Seng Biotech Index - HKD - Benchmark TR Gross. ETFs usually track some benchmark seeking to replicate its performance and guide asset selection and objectives.
159615 invests in stocks.
159615 price has fallen by −2.70% over the last month, and its yearly performance shows a 94.89% increase. See more dynamics on 159615 price chart.
NAV returns, another gauge of an ETF dynamics, have risen by −2.16% over the last month, have fallen by −2.16% over the last month, showed a 27.62% increase in three-month performance and has increased by 103.20% in a year.
NAV returns, another gauge of an ETF dynamics, have risen by −2.16% over the last month, have fallen by −2.16% over the last month, showed a 27.62% increase in three-month performance and has increased by 103.20% in a year.
159615 trades at a premium (1.21%) meaning the ETF is trading at a higher price than the calculated NAV.